EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system

Ching-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, Chao-Chi Ho, Chia-Lin Hsu, Tzu-Hsiu Tsai, Shang-Gin Wu, Yen-Ting Lin, Wei-Hsun Hsu, Suyog Jain, Steve Olsen, James Chih-Hsin Yang und 2 weitere

European Journal of Cancer · 2023

DOI: 10.1016/j.ejca.2023.113310 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Journal of Cancer, 2023. Verfasst von Ching-Yao Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, High-Throughput Nucleotide Sequencing, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsHigh-Throughput Nucleotide SequencingBiomarkers, TumorHumansFemaleMaleMiddle AgedAgedProspective StudiesMutationAdultTaiwanErbB ReceptorsAged, 80 and over

Stichwörter der Autor:innen

CfDNALiquid biopsyLung cancerNGS

Substanzen

Biomarkers, TumorErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: jyshih@ntu.edu.tw.
  • Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan.
  • Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan.
  • Deparment of Medical Affairs, Guardant Health AMEA, Singapore.
  • Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.

Zitieren

APA

Yang, C. Y., Shih, J. Y., Liao, W. Y., Ho, C. C., Hsu, C. L., Tsai, T. H., Wu, S. G., Lin, Y. T., Hsu, W. H., Jain, S., Olsen, S., Yang, J. C., Yu, C. J., & Yang, P. C. (2023). Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.113310

Vancouver

Yang CY, Shih JY, Liao WY, Ho CC, Hsu CL, Tsai TH, et al. Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system. European Journal of Cancer. 2023. doi:10.1016/j.ejca.2023.113310

BibTeX
@article{Yang2023,
  author = {Yang, Ching-Yao and Shih, Jin-Yuan and Liao, Wei-Yu and Ho, Chao-Chi and Hsu, Chia-Lin and Tsai, Tzu-Hsiu and Wu, Shang-Gin and Lin, Yen-Ting and Hsu, Wei-Hsun and Jain, Suyog and Olsen, Steve and Yang, James Chih-Hsin and Yu, Chong-Jen and Yang, Pan-Chyr},
  title = {Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system},
  journal = {European Journal of Cancer},
  year = {2023},
  doi = {10.1016/j.ejca.2023.113310}
}
Kostenlos starten →